178 related articles for article (PubMed ID: 25377444)
1. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment.
Sacktor N; Miyahara S; Evans S; Schifitto G; Cohen B; Haughey N; Drewes JL; Graham D; Zink MC; Anderson C; Nath A; Pardo CA; McCarthy S; Hosey L; Clifford D;
J Neurovirol; 2014 Dec; 20(6):620-6. PubMed ID: 25377444
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment.
Nakasujja N; Miyahara S; Evans S; Lee A; Musisi S; Katabira E; Robertson K; Ronald A; Clifford DB; Sacktor N
Neurology; 2013 Jan; 80(2):196-202. PubMed ID: 23269596
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial.
Sacktor N; Skolasky RL; Moxley R; Wang S; Mielke MM; Munro C; Steiner J; Nath A; Haughey N; McArthur J
J Neurovirol; 2018 Feb; 24(1):16-27. PubMed ID: 29063516
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Biomarkers in Human Spinal Cord Injury from a Phase II Minocycline Trial.
Casha S; Rice T; Stirling DP; Silva C; Gnanapavan S; Giovannoni G; Hurlbert RJ; Yong VW
J Neurotrauma; 2018 Aug; 35(16):1918-1928. PubMed ID: 30074872
[TBL] [Abstract][Full Text] [Related]
6. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
McGuire JL; Gill AJ; Douglas SD; Kolson DL;
J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
[TBL] [Abstract][Full Text] [Related]
7. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).
Ndhlovu LC; Umaki T; Chew GM; Chow DC; Agsalda M; Kallianpur KJ; Paul R; Zhang G; Ho E; Hanks N; Nakamoto B; Shiramizu BT; Shikuma CM
J Neurovirol; 2014 Dec; 20(6):571-82. PubMed ID: 25227930
[TBL] [Abstract][Full Text] [Related]
8. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
Aweeka F; Jayewardene A; Staprans S; Bellibas SE; Kearney B; Lizak P; Novakovic-Agopian T; Price RW
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):39-43. PubMed ID: 9928728
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
[TBL] [Abstract][Full Text] [Related]
10. Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial.
Sacktor N; Miyahara S; Deng L; Evans S; Schifitto G; Cohen BA; Paul R; Robertson K; Jarocki B; Scarsi K; Coombs RW; Zink MC; Nath A; Smith E; Ellis RJ; Singer E; Weihe J; McCarthy S; Hosey L; Clifford DB;
Neurology; 2011 Sep; 77(12):1135-42. PubMed ID: 21900636
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
Cassol E; Misra V; Dutta A; Morgello S; Gabuzda D
AIDS; 2014 Jul; 28(11):1579-91. PubMed ID: 24752083
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.
Goodkin K; Vitiello B; Lyman WD; Asthana D; Atkinson JH; Heseltine PN; Molina R; Zheng W; Khamis I; Wilkie FL; Shapshak P
J Neurovirol; 2006 Jun; 12(3):178-89. PubMed ID: 16877299
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
[TBL] [Abstract][Full Text] [Related]
15. Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report.
Andersson LM; Hagberg L; Rosengren L; Fuchs D; Blennow K; Gisslén M
BMC Infect Dis; 2006 Sep; 6():141. PubMed ID: 16978408
[TBL] [Abstract][Full Text] [Related]
16. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
Bogoch II; Davis BT; Venna N
J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
[TBL] [Abstract][Full Text] [Related]
17. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
Yuan NY; Kaul M
J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
[TBL] [Abstract][Full Text] [Related]
18. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
19. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
[TBL] [Abstract][Full Text] [Related]
20. Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.
Lentz MR; Degaonkar M; Mohamed MA; Kim H; Conant K; Halpern EF; Sacktor N; Barker PB; Pomper MG
J Neurovirol; 2010 Oct; 16(5):368-76. PubMed ID: 20839921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
